University of Leicester
Browse
HF_CAUSES_BIOSTAT_11022019 JPF_AV.pdf (2 MB)

Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF

Download (2 MB)
journal contribution
posted on 2020-03-30, 13:36 authored by Masatake Kobayashi, Adriaan A. Voors, Nicolas Girerd, Maxime Billotte, Stefan D. Anker, John G. Cleland, Chim C. Lang, Leong L. Ng, Dirk J. van Veldhuisen, Kenneth Dickstein, Macro Metra, Kevin Duarte, Patrick Rossignol, Faiez Zannad, Joao P. Ferreira
Background: Knowledge on the association between heart failure (HF) etiologies, precipitant causes and clinical outcomes may help in ascertaining patient's risk and in selecting tailored therapeutic strategies. Methods: The prognostic value of both HF etiologies and precipitants for worsening HF were analyzed using the index cohort of BIOSTAT-CHF. The studied HF etiologies were: a) ischemic HF; b) dilated cardiomyopathy; c) hypertensive HF; d) valvular HF; and e) other/unknown. The precipitating factors for worsening HF were: a) atrial fibrillation; b) non-adherence; c) renal failure; d) acute coronary syndrome; e) hypertension; and f) Infection. The primary outcome was the composite of all-cause death or HF hospitalization. Results: Among 2465 patients included in the study, 45% (N = =1102) had ischemic HF, 23% (N = =563) dilated cardiomyopathy, 15% (N = =379) other/unknown, 10% (N = =237) hypertensive and 7% (N = =184) valvular HF. Patients with ischemic HF had the worst prognosis, whereas patients with dilated cardiomyopathy had the best prognosis. From the precipitating factors for worsening HF, renal failure was the one independently associated with worse prognosis (adjusted HR (95%CI) = =1.48 (1.04–2.09), p < 0.001). We found no interaction between HF etiologies and precipitating factors for worsening HF with regard to the study outcomes (p interaction > 0.10 for all). Treatment up-titration benefited patients regardless of their underlying etiology or precipitating cause (p interaction > 0.10 for all). Conclusions: In BIOSTAT-CHF, patients with HF of an ischemic etiology, and those with worsening HF precipitated by renal failure (irrespective of the underlying HF etiology), had the highest rates of death and HF hospitalization, but still benefited equally from treatment up-titration.

History

Citation

European Journal of Internal Medicine, 71 (2020), 62–69

Author affiliation

Department of Cardiovascular Sciences

Version

  • AM (Accepted Manuscript)

Published in

European Journal of Internal Medicine

Volume

71

Pagination

62–69

Publisher

Elsevier BV

issn

0953-6205

eissn

1879-0828

Acceptance date

2019-10-12

Copyright date

2019

Available date

2019-11-08

Publisher version

https://www.sciencedirect.com/science/article/pii/S0953620519303541

Spatial coverage

Netherlands

Language

eng

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC